Tagrisso Tablets Clinical Experience Investigation (All case investigation)

Trial Identifier: D5160C00025
Sponsor: AstraZeneca
NCTID:: NCT02756039
Start Date: May 2016
Primary Completion Date: August 2018
Study Completion Date: August 2018
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations